Thyroid Hormone Receptors as Tumor Suppressors in Cancer
Endocrinology · 27.08.2024 · 165 (10)
DOI: 10.1210/endocr/bqae115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 03.09.2024. Verfasst von Xuguang Zhu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA. Hauptthemen laut MEDLINE: Neoplasms, Receptors, Thyroid Hormone. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
Accumulated research has revealed the multifaceted roles of thyroid hormone receptors (TRs) as potent tumor suppressors across various cancer types. This review explores the intricate mechanisms underlying TR-mediated tumor suppression, drawing insights from preclinical mouse models and cancer biology. This review examines the tumor-suppressive functions of TRs, particularly TRβ, in various cancers using preclinical models, revealing their ability to inhibit tumor initiation, progression, and metastasis. Molecular mechanisms underlying TR-mediated tumor suppression are discussed, including interactions with oncogenic signaling pathways like PI3K-AKT, JAK-STAT, and transforming growth factor β. Additionally, this paper examines TRs’ effect on cancer stem cell activity and differentiation, showcasing their modulation of key cellular processes associated with tumor progression and therapeutic resistance. Insights from preclinical studies underscore the therapeutic potential of targeting TRs to impede cancer stemness and promote cancer cell differentiation, paving the way for precision medicine in cancer treatment and emphasizing the potential of TR-targeted therapies as promising approaches for treating cancers and improving patient outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.
ORCID-Profile: Xuguang Zhu, Sheue-Yann Cheng
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Zhu, X., & Cheng, S. Y. (2024). Thyroid Hormone Receptors as Tumor Suppressors in Cancer. Endocrinology, 165(10). https://doi.org/10.1210/endocr/bqae115
Vancouver
Zhu X, Cheng SY. Thyroid Hormone Receptors as Tumor Suppressors in Cancer. Endocrinology. 2024;165(10). doi:10.1210/endocr/bqae115
BibTeX
@article{Zhu2024,
author = {Zhu, Xuguang and Cheng, Sheue-Yann},
title = {Thyroid Hormone Receptors as Tumor Suppressors in Cancer},
journal = {Endocrinology},
year = {2024},
volume = {165},
number = {10},
doi = {10.1210/endocr/bqae115}
}
EUVIMED